Management Team

Werner Tschollar | Chief Executive Officer

Dr. Werner Tschollar

Chief Executive Officer, President of the Board

  • Founder and board member
  • Overall strategic leadership
  • Drug development, regulatory affairs, business development and investor relations

Caspar Graf von Moy | Chief Operating Officer

Caspar Graf von Moy

Chief Operating Officer

  • Founder and board member
  • Operations, legal, business development and investor relations



Patrick Schacher | Chief Financial Officer

Patrick Schacher

Chief Financial Officer

  • Finance management, budgeting, controlling, corporate governance, tax, IT and business development


Prof. Dr. Werner Weitschies | Chief Scientific Advisor

Prof. Dr. Werner Weitschies

Chief Scientific Advisor

  • Expert in pharmaceutical technologies, gastro-intestinal models, formulation development and testing.



Board of Directors

Dr. Werner Tschollar

President of the Board, CEO, founder

Caspar Graf von Moy

Board member, COO, founder

Dr. Thomas Zehnder

Board Member, founder


  • General Partner at BlueOcean Ventures SA
  • Member of the board in various private and public companies in Switzerland, USA and Sweden


  • President & CEO of Spinelab AG
  • Executive positions at Sulzer Medica AG, Covance Inc. and Synthes Inc.

Philip Burchard

Observatory position at the Board


  • CEO at Merz Pharma GmbH & Co. KGaA


  • Senior Vice President Global Marketing and Sales Operations, AstraZeneca PLC
  • Area Vice President Western Europe, AstraZeneca PLC

Advisory Board

Prof. Dr. Werner Weitschies

  • Head of Biopharmacy and Pharmaceutical Technologies at the Center of Drug Absorption and Transport (C_DAT), University of Greifswald
  • Professor at the Institute of Pharmacy, University of Greifswald

Prof. Dr. med. Dr. phil. Gerhard Rogler

  • Professor of Gastroenterology and Hepatology, University of Zurich
  • President of the Swiss Celiac Disease Society
  • Head of IBD, Novartis professorship

Prof. Dr. Rolf Bass MD, FFPM (Hon) (RCP-UK)


  • Head of the Human Medicines Evaluation Unit at the European Medicines Agency, EMA, in London
  • Professor for Pharmacology and Toxicology: Charité-University Berlin
  • Visiting Professor for Pharmaceutical Medicine, University of Basel

Dr. Gerd Bode


  • Member of the Arzneimittel-Kommission at BfARM
  • Head Drug Safety at Altana Pharma AG
  • Head, preclinical research at Hoechst-Marion-Roussel (Pharmacology, Toxicology, Kinetics, Metabolism, Clinical Phase I)
  • Head of experimental medicine at Boehring Mannheim

Prof. Dr. med. Thomas Gramatté

  • Expert for preclinical and clinical drug development
  • Adjunct Professor for Clinical Pharmacology at the University of Dresden, School of Medicine


  • Morphochem AG, Munich: Vice President Medical Affairs and Clinical Development
  • Apogepha Arzneimittel GmbH, Dresden: Director Medical Research